Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.790
-0.090 (-1.84%)
May 30, 2025, 2:24 PM - Market open
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $36.10 million as of May 30, 2025. Its market cap has increased by 214.63% in one year.
Market Cap
36.10M
Enterprise Value
11.85M
1-Year Change
214.63%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $36.10M, a decrease of -50.45%. That is a compound annual growth rate of -18.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 36.04M | 10.63% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |